Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer (Q62105104)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer |
clinical trial |
Statements
Randomized, Phase II, Open-Label Controlled Study of Two Different Doses and Schedules of EMD 72000 (Matuzumab) in Combination With Pemetrexed, or Pemetrexed Alone, as Second-Line Treatment for Stage IIIB/IV Non-Small Cell Lung Cancer and Progressive Disease on or After First-Line Treatment With a Platinum in Combination With Taxanes, Gemcitabine and Vinorelbine (English)
0 references
31 May 2005
0 references
31 July 2007
0 references
150
0 references